LKFT is Lakefront Biotherapeutics NV (Healthcare) — a non-dividend-paying stock. Trading at $28.49. Market cap: $1.87B.
Stock snapshot
| Price | $28.49 |
| Market cap | $1.87B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About LKFT
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
Related non-dividend companies
Other non-dividend stocks investors research alongside LKFT. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LKFT's current stock price?
LKFT (Lakefront Biotherapeutics NV) is currently trading at $28.49.
Does LKFT pay a dividend?
LKFT (Lakefront Biotherapeutics NV) does not currently pay a regular dividend.
Track LKFT in DiviDrip
Add LKFT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LKFT and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.